El-Naggar A K, Hurr K, Huff V, Luna M A, Goepfert H, Batsakis J G
Departments of Pathology, Experimental Pediatrics, and Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
Clin Cancer Res. 1996 May;2(5):903-7.
The frequent loss of heterozygosity (LOH) demonstrated at chromosome 11p regions in several sporadic malignancies has suggested the presence of tumor suppressor genes at these locations. To obtain detailed mapped incidence of the microsatellite alterations at these regions and to investigate the possible correlation between the genotype and the pathobiological characteristics of head and neck squamous carcinoma, we analyzed paired DNA samples from normal mucosa and primary tumor specimens from 56 patients with these tumors. Our results show that 50.9% of the tumors had microsatellite alterations at one or more of these loci. LOH was manifested in 45. 5% and instability in 5.5% of the tumors. 11p15 loci showed more frequent LOH (39.6%) than those of 11p13 (29.3%) and 11p11-12 (18. 8%); the D11S988 (11p15) marker showed the highest single locus incidence of LOH (29.7%). Eight tumors (22.2%) demonstrated simultaneous LOH at both the 11p15 and 11p13 regions. LOH was significantly associated with poor histological differentiation, DNA aneuploidy, and high proliferative activity in these neoplasms. Our study extends the involvement of the 11p13 and 11p15 regions to head and neck squamous tumorigenesis and indicates that the terminal loci of 11p may harbor a tumor suppressor gene(s) associated with the progression of these tumors.
在几种散发性恶性肿瘤中,11号染色体短臂(11p)区域频繁出现杂合性缺失(LOH),这提示这些位置存在肿瘤抑制基因。为了详细绘制这些区域微卫星改变的发生率图谱,并研究头颈部鳞状细胞癌的基因型与病理生物学特征之间的可能相关性,我们分析了56例此类肿瘤患者的正常黏膜和原发性肿瘤标本的配对DNA样本。我们的结果显示,50.9%的肿瘤在这些位点中的一个或多个位点存在微卫星改变。45.5%的肿瘤表现为LOH,5.5%表现为不稳定性。11p15位点的LOH发生率(39.6%)高于11p13(29.3%)和11p11 - 12(18.8%);D11S988(11p15)标记显示出最高的单个位点LOH发生率(29.7%)。8例肿瘤(22.2%)在11p15和11p13区域同时出现LOH。在这些肿瘤中,LOH与组织学分化差、DNA非整倍体和高增殖活性显著相关。我们的研究将11p13和11p15区域的作用扩展到头颈部鳞状肿瘤发生过程中,并表明11p的末端位点可能含有与这些肿瘤进展相关的一个或多个肿瘤抑制基因。